2024
Longitudinal Follow-up of Medicare Patients after Esophageal Cancer Resection in the STS Database
Blasberg J, Servais E, Thibault D, Jacobs J, Kozower B, David E, Donahue J, Vekstein A, Kang L, Hartwig M, Jones L, Kosinski A, Habib R, Towe C, Seder C. Longitudinal Follow-up of Medicare Patients after Esophageal Cancer Resection in the STS Database. The Annals Of Thoracic Surgery 2024 PMID: 39147116, DOI: 10.1016/j.athoracsur.2024.07.034.Peer-Reviewed Original ResearchIncreased mortality riskLong-term mortalityMedicare patientsMortality riskDays post-surgeryPost-surgeryCox proportional hazards modelsMultivariate Cox proportional hazards modelDown-staged patientsCharacteristics associated with survivalEsophageal cancer resectionPreoperative risk stratificationProportional hazards modelLog-rank testLong-term survivalDeterministic matching algorithmLongitudinal follow-upPatient-specific predictorsShort-term mortalityCumulative incidence curvesDownstaged patientsN downstagingSTS databasePathological TCancer resection
2016
Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall
Gao SJ, Corso CD, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall. Clinical Lung Cancer 2016, 18: 169-177.e4. PMID: 27890561, DOI: 10.1016/j.cllc.2016.08.005.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerAdjuvant chemotherapyAdjuvant chemoradiation therapyUnderwent surgeryChemoradiation therapyChest wall resectionRadiation therapyMargin statusTumor sizeLung cancerWall resectionNode-negative lung cancerNational Cancer Data BaseCox proportional hazards modelMargin-positive patientsChest wall invasionCell lung cancerLog-rank testStage IIB tumorsProportional hazards modelAdjuvant therapyAdjuvant treatmentOverall survivalMultivariable analysisIIB tumorsTiming of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non–Small Cell Lung Cancer
Gao SJ, Corso CD, Wang EH, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non–Small Cell Lung Cancer. Journal Of Thoracic Oncology 2016, 12: 314-322. PMID: 27720827, DOI: 10.1016/j.jtho.2016.09.122.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaCarcinoma, Large CellCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellChemoradiotherapy, AdjuvantCombined Modality TherapyFemaleFollow-Up StudiesHumansLung NeoplasmsMaleMiddle AgedNeoadjuvant TherapyNeoplasm StagingPneumonectomyPrognosisRetrospective StudiesSurvival RateTime FactorsConceptsNational Cancer Data BaseNeoadjuvant chemoradiationTiming of surgeryOverall survivalAdvanced non-small cell lung cancerNon-small cell lung cancerStage IIIA-N2 NSCLCStage IIIA NSCLCKaplan-Meier methodOverall survival rateSubset of patientsCell lung cancerLog-rank testMultivariate survival analysisProportional hazards modelIIIA NSCLCN2 NSCLCNeoadjuvant therapyTrimodality therapySurgical resectionClinical stageRetrospective studyLung cancerHazards modelSurvival rate